The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

BTOG 2018 | Rapid diagnostic pathways for lung cancer

Name: Rapid diagnostic pathways for lung cancer
Uploaded: 2018-01-24T00:00:00Z
Duration: 1 min 29 s
Description: Reducing the length of diagnostic pathways can increase the number treatment options available and enable better patient experiences. Here, Neal Navani, PhD, of University College London Hospitals NHS Foundation Trust, London, UK, discusses exciting data in this area from the British Thoracic Oncology Group (BTOG) Annual Conference 2018, held in Dublin, Ireland.

Neal Navani • 24 Jan 2018

BTOG 2018

Lung Cancer Non-Small Cell Lung Cancer Small Cell Lung Cancer

Reducing the length of diagnostic pathways can increase the number treatment options available and enable better patient experiences. Here, Neal Navani, PhD, of University College London Hospitals NHS Foundation Trust, London, UK, discusses exciting data in this area from the British Thoracic Oncology Group (BTOG) Annual Conference 2018, held in Dublin, Ireland.